Embecta Corp. (EMBC)
NASDAQ: EMBC · IEX Real-Time Price · USD
10.31
-0.09 (-0.87%)
Apr 26, 2024, 4:00 PM EDT - Market closed
Company Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes.
Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes.
The company primarily sells its products to wholesalers and distributors in the United States and internationally.
Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
Embecta Corp.
| Country | United States |
| Founded | 1924 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 2,200 |
| CEO | Devdatt Kurdikar |
Contact Details
Address: 1209 Orange Street Wilmington, Delaware 19801 United States | |
| Phone | (862) 401-0000 |
| Website | embecta.com |
Stock Details
| Ticker Symbol | EMBC |
| Exchange | NASDAQ |
| Fiscal Year | October - September |
| Reporting Currency | USD |
| CIK Code | 0001872789 |
| CUSIP Number | 29082K105 |
| ISIN Number | US29082K1051 |
| Employer ID | 87-1583942 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Devdatt Kurdikar | President, Chief Executive Officer and Director |
| Jacob P. Elguicze | Senior Vice President and Chief Financial Officer |
| Brian R. Capone | Vice President, Chief Accounting Officer and Corporate Controller |
| Jeffrey Z. Mann | Senior Vice President, General Counsel, Head of Business Development and Corporate Secretary |
| Shaun Curtis | Senior Vice President of Global Manufacturing and Supply Chain |
| Colleen Riley | Senior Vice President and Chief Technology Officer |
| Pravesh Khandelwal | Vice President and Head of Investor Relations |
| Ginny Blocki | Senior Vice President of Global Marketing and Product Management |
| Jean M. Casner | Senior Vice President and Chief Human Resources Officer |
| Tom Blount | Senior Vice President and President of North America |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 5, 2024 | 10-K/A | [Amend] Annual report |
| Mar 28, 2024 | 8-K | Current Report |
| Feb 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Feb 13, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Feb 12, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Feb 9, 2024 | 8-K | Current Report |
| Feb 9, 2024 | 10-Q | Quarterly Report |
| Feb 9, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Feb 9, 2024 | 8-K | Current Report |
| Jan 30, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |